Thus, IL-4 and IL-13 are factors that aggravate the inflammatory response in asthma, and there are also many studies that have achieved control of Th2-type asthma by preparing IL-4 and IL-13 antibodies (Bagnasco et al., 2016; Godar et al., 2018). Here, IL4 is linked to asthma.